SCIASCIA THOMAS
Insider CIK 1229946 · TRVI Chief Scientific Officer, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2026-02-19 | 2026-02-20 | 85,000 | — | $0 | 85,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2025-05-31 | 2025-06-03 | 60,000 | — | $0 | 92,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise deriv | 2025-03-25 | 2025-03-26 | 2,631 | — | $0 | 0 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise | 2025-03-25 | 2025-03-26 | 2,631 | $1.43 | $3.8K | 224,004 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | S Sale | 2025-03-25 | 2025-03-26 | 2,631 | $6.60 | $17.4K | 221,373 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2025-03-10 | 2025-03-12 | 32,000 | — | $0 | 32,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2025-02-18 | 2025-02-20 | 116,000 | — | $0 | 116,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise deriv | 2024-08-19 | 2024-08-21 | 16,496 | — | $0 | 0 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | S Sale | 2024-08-19 | 2024-08-21 | 16,496 | $2.96 | $48.8K | 220,315 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise | 2024-08-19 | 2024-08-21 | 16,496 | $1.43 | $23.6K | 236,811 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise deriv | 2024-08-16 | 2024-08-16 | 18,660 | — | $0 | 16,496 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | S Sale | 2024-08-16 | 2024-08-16 | 18,660 | $2.76 | $51.5K | 220,315 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise | 2024-08-16 | 2024-08-16 | 18,660 | $1.43 | $26.7K | 238,975 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise deriv | 2024-08-15 | 2024-08-16 | 12,745 | — | $0 | 35,156 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | S Sale | 2024-08-15 | 2024-08-16 | 12,745 | $2.79 | $35.6K | 220,315 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise | 2024-08-15 | 2024-08-16 | 12,745 | $1.43 | $18.2K | 233,060 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise deriv | 2024-08-14 | 2024-08-16 | 100 | — | $0 | 47,901 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise | 2024-08-14 | 2024-08-16 | 100 | $1.43 | $143 | 220,415 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | S Sale | 2024-08-14 | 2024-08-16 | 100 | $2.75 | $275 | 220,315 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise deriv | 2024-05-29 | 2024-05-31 | 59,354 | — | $0 | 0 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise | 2024-05-29 | 2024-05-31 | 59,354 | $2.19 | $130.0K | 267,801 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | S Sale | 2024-05-29 | 2024-05-31 | 53,368 | $2.55 | $136.1K | 214,433 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2024-02-15 | 2024-02-16 | 150,000 | — | $0 | 150,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2023-02-16 | 2023-02-16 | 187,500 | — | $0 | 187,500 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2022-09-19 | 2022-09-19 | 7,500 | — | $0 | 37,500 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2022-06-29 | 2022-07-01 | 30,000 | — | $0 | 30,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2022-02-11 | 2022-07-01 | 110,000 | — | $0 | 110,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2022-02-11 | 2022-02-15 | 110,000 | — | $0 | 110,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2021-02-17 | 2021-02-19 | 50,000 | — | $0 | 50,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2020-02-13 | 2020-02-18 | 60,000 | — | $0 | 60,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2019-06-03 | 2019-06-05 | 50,000 | — | $0 | 50,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | C Conversion deriv | 2019-05-09 | 2019-05-13 | 13,410 | — | $0 | 0 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | C Conversion deriv | 2019-05-09 | 2019-05-13 | 109,015 | — | $0 | 0 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | C Conversion | 2019-05-09 | 2019-05-13 | 17,118 | — | $0 | 193,724 | SEC↗ |